Blood-Based Biomarkers for Monitoring Treatment Response in Multiple Sclerosis

28 Oct 2026 0 comments

Kim Henriksen, PhD, discusses research evaluating blood-based biomarkers of blood-brain barrier remodeling and immune cell activity in multiple sclerosis, including their potential to track treatment responses and inform future biomarker development.

Source: NeurologyLive Published 28 Oct 2026 Imported 28 Oct 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment